Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing …
5 days ago · One-time infusion of investigational CRISPR-Cas9 therapy found to safely reduce LDL cholesterol by 50% and triglycerides by about 55% in Phase 1 trial
First-in-human trial of CRISPR gene-editing therapy safely …
6 days ago · Research Highlights: In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was …
CRISPR gene-editing works to reduce high cholesterol in a new …
6 days ago · An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, possibly helping cut the risk for heart disease.
CRISPR Medicine News - Learn | Innovate | Access
Oct 22, 2025 · At CRISPR Medicine News we focus on topics related to genetic medicine, gene therapy and genome editing using CRISPR for treatment of human diseases. We strive to …
First-in-human trial of CRISPR gene-editing therapy safely lowers …
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and triglycerides in people with difficult-to-treat lipid disorders ...
Scientists just made CRISPR three times more effective
Sep 7, 2025 · CRISPR gets a major boost from DNA-coated nanostructures that supercharge delivery and precision. Northwestern scientists have developed a new nanostructure that …
CRISPR Therapeutics Announces Positive Phase 1 Clinical
5 days ago · CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering …
CRISPR | MIT News | Massachusetts Institute of Technology
Sep 30, 2025 · Researchers develop a fast-acting, cell-permeable protein system to control CRISPR-Cas9, reducing off-target effects and advancing gene therapy. Combining powerful …
CRISPR’s efficiency triples with DNA-wrapped nanoparticles
Sep 5, 2025 · Now, Northwestern University chemists have unveiled a new type of nanostructure that dramatically improves CRISPR delivery and potentially extends its scope of utility.
CRISPR-Cas systems - Latest research and news | Nature
Nov 7, 2025 · CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been …